Want to see SSII full AI Analyst Report?
SSII Stock Chart & Stats
$3.83
$0.03(0.80%)
At close: 4:00 PM EDT
$3.83
$0.03(0.80%)
Day’s Range― - ―
52-Week Range$2.57 - $10.00
Previous Close$3.95
Volume11.27K
Average Volume (3M)63.19K
Market Cap
$530.27M
Enterprise Value$826.14M
Total Cash (Recent Filing)$13.65M
Total Debt (Recent Filing)$3.24M
Price to Earnings (P/E)―
Beta0.60
Next Earnings
Nov 03, 2026EPS Estimate
-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding200,478,420
10 Day Avg. Volume64,166
30 Day Avg. Volume63,193
Financial Highlights & Ratios
PEG Ratio2.12
Price to Book (P/B)28.24
Price to Sales (P/S)25.40
P/FCF Ratio-48.61
Enterprise Value/Market Cap1.56
Enterprise Value/Revenue15.77
Enterprise Value/Gross Profit33.54
Enterprise Value/Ebitda-133.11
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)$60.00M
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthRapid revenue expansion indicates increasing adoption of SS Innovations’ robotic surgery platform and improving commercial scale. The concurrent gross-margin improvement suggests growth is not entirely volume-driven and could provide a stronger foundation for future operating leverage as installations mature.
Improving Balance Sheet LeverageThe sharp reduction in leverage materially improves financial resilience compared with prior years. A stronger equity base and lower debt burden reduce refinancing and solvency pressure, giving management greater flexibility to support product development and commercial expansion over the coming quarters.
Growing Installed Base And Clinical AdoptionA larger installed base and rising procedure volume support the platform’s clinical acceptance and create a broader foundation for recurring utilization, training, and service opportunities. International expansion also gives SS Innovations room to build market position in underpenetrated robotic-surgery regions.
Bears Say
Persistent Operating And Net LossesThe company has not yet converted strong sales growth into sustainable profitability. Continued operating and net losses indicate that fixed costs, commercial investment, or other expenses still absorb much of the gross profit, leaving earnings power vulnerable if growth moderates before scale benefits emerge.
Persistent Cash BurnNegative operating and free cash flow show that the business is not yet self-funding its expansion. Continued cash burn can require additional financing, constrain investment choices, and increase dependence on capital availability until installations and procedures generate sufficient operating cash.
Negative Returns On EquityA negative return on equity indicates that the enlarged equity base is not currently producing positive returns for shareholders. Unless operating losses narrow, capital raised or retained in the business may remain inefficiently deployed, limiting the economic benefit of balance-sheet improvement.
SS Innovations International News
SSII FAQ
What was SS Innovations International’s price range in the past 12 months?
SS Innovations International lowest stock price was $2.57 and its highest was $10.00 in the past 12 months.
What is SS Innovations International’s market cap?
SS Innovations International’s market cap is $530.27M.
When is SS Innovations International’s upcoming earnings report date?
SS Innovations International’s upcoming earnings report date is Nov 03, 2026 which is in 23 days.
How were SS Innovations International’s earnings last quarter?
SS Innovations International released its earnings results on Aug 13, 2026. The company reported -$0.01 earnings per share for the quarter.
Is SS Innovations International overvalued?
According to Wall Street analysts SS Innovations International’s price is currently Overvalued.
Does SS Innovations International pay dividends?
SS Innovations International does not currently pay dividends.
What is SS Innovations International’s EPS estimate?
SS Innovations International’s EPS estimate is -0.01.
How many shares outstanding does SS Innovations International have?
SS Innovations International has 200,478,420 shares outstanding.
What happened to SS Innovations International’s price movement after its last earnings report?
SS Innovations International reported an EPS of -$0.01 in its last earnings report. Following the earnings report the stock price went up 3.794%.
Which hedge fund is a major shareholder of SS Innovations International?
Currently, no hedge funds are holding shares in SSII
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SS Innovations International Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Neutral
SSII Sentiment 50%
Sector Average 66%
Sector Average 66%
Insider Transactions
Sold Shares
Worth $100.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 1.5%
Last 30 Days ▼ 0.4%
Last 30 Days ▼ 0.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-60.89%
12-Months-Change
Fundamentals
Return on Equity
-26.77%
Trailing 12-Months
Asset Growth
38.59%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
SS Innovations International
SS Innovations International, Inc., situated in Fort Lauderdale, Florida, focuses on the development of sophisticated robotic systems for surgical use. Their offerings encompass the SSI Mantra, a specialized surgical robot, and SSI Mudra, a suite of surgical instruments designed to facilitate various operations, including robotic cardiac surgery. The company also provides SSI Maya, a dedicated platform for robotic surgical interventions, along with OMNI 3D HD, which delivers a real-time, high-definition 3D perspective of the surgical field within the operating room.
Technical Analysis
Ownership Overview
67.53% Insiders
0.46% Mutual Funds
0.74% Other Institutional Investors
31.16% Public Companies and
Individual Investors